Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 01 09 2019
accepted: 14 03 2020
pubmed: 1 7 2020
medline: 1 1 2021
entrez: 30 6 2020
Statut: ppublish

Résumé

Chronic hypoxia may play a pivotal role in the development of diabetic nephropathy (DN). However, the precise mechanisms underlying progressive hypoxia-induced glomerular injury remain unclear. We housed db/db mice in a hypoxia chamber (12% O2) for up to 16 weeks beginning at 8 weeks of age. Various urine, serum and kidney abnormalities and glomerular messenger RNA (mRNA) expression were compared with those in age-matched db/db mice housed under normoxia. Levels of urinary albumin and podocalyxin (PCX) were significantly higher in hypoxic mice early during hypoxia. Ultracentrifugation of urine samples revealed that podocytes in the hypoxic mice shed PCX-positive microparticles into the urine. After 16 weeks of hypoxia, the mice also had higher hematocrits with lower serum glucose and various degrees of mesangiolytic glomerulosclerosis with microaneurysms and the infrequent occurrence of nodular lesions. Immunohistologically, hypoxic mice showed significantly decreased endothelial cell densities early during hypoxia and decreased podocyte densities later. In both hypoxic and normoxic mice, glomerular macrophage and transforming growth factor-β1 (TGF-β1) staining significantly increased with aging, without changes in vascular endothelial growth factor or endothelial nitric oxide synthase (eNOS). Glomerular mRNA expression of monocyte chemoattractant protein-1, eNOS and TGF-β1 was significantly enhanced in the hypoxic mice. These results indicate that chronic hypoxia induces advanced glomerulosclerosis with accelerated albuminuria triggered by mesangiolysis and podocyte injury in a murine model of DN.

Sections du résumé

BACKGROUND
Chronic hypoxia may play a pivotal role in the development of diabetic nephropathy (DN). However, the precise mechanisms underlying progressive hypoxia-induced glomerular injury remain unclear.
METHODS
We housed db/db mice in a hypoxia chamber (12% O2) for up to 16 weeks beginning at 8 weeks of age. Various urine, serum and kidney abnormalities and glomerular messenger RNA (mRNA) expression were compared with those in age-matched db/db mice housed under normoxia.
RESULTS
Levels of urinary albumin and podocalyxin (PCX) were significantly higher in hypoxic mice early during hypoxia. Ultracentrifugation of urine samples revealed that podocytes in the hypoxic mice shed PCX-positive microparticles into the urine. After 16 weeks of hypoxia, the mice also had higher hematocrits with lower serum glucose and various degrees of mesangiolytic glomerulosclerosis with microaneurysms and the infrequent occurrence of nodular lesions. Immunohistologically, hypoxic mice showed significantly decreased endothelial cell densities early during hypoxia and decreased podocyte densities later. In both hypoxic and normoxic mice, glomerular macrophage and transforming growth factor-β1 (TGF-β1) staining significantly increased with aging, without changes in vascular endothelial growth factor or endothelial nitric oxide synthase (eNOS). Glomerular mRNA expression of monocyte chemoattractant protein-1, eNOS and TGF-β1 was significantly enhanced in the hypoxic mice.
CONCLUSIONS
These results indicate that chronic hypoxia induces advanced glomerulosclerosis with accelerated albuminuria triggered by mesangiolysis and podocyte injury in a murine model of DN.

Identifiants

pubmed: 32596728
pii: 5864515
doi: 10.1093/ndt/gfaa074
doi:

Substances chimiques

Tgfb1 protein, mouse 0
Transforming Growth Factor beta1 0
Vascular Endothelial Growth Factor A 0
Nitric Oxide Synthase Type III EC 1.14.13.39

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1678-1688

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Auteurs

Naoki Takahashi (N)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Haruyoshi Yoshida (H)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Department of Internal Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Fukui, Japan.

Hideki Kimura (H)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Department of Clinical Laboratory, University of Fukui Hospital, Fukui, Japan.

Kazuko Kamiyama (K)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Tomomi Kurose (T)

Department of Clinical Laboratory, University of Fukui Hospital, Fukui, Japan.

Hidehiro Sugimoto (H)

Department of Clinical Laboratory, University of Fukui Hospital, Fukui, Japan.

Toshio Imura (T)

Department of Clinical Laboratory, University of Fukui Hospital, Fukui, Japan.

Seiji Yokoi (S)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Daisuke Mikami (D)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Kenji Kasuno (K)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Hiroyuki Kurosawa (H)

Reagent R&D Department, Denka Seiken Co., Ltd, Gosen, Niigata, Japan.

Yoshiaki Hirayama (Y)

Reagent R&D Department, Denka Seiken Co., Ltd, Gosen, Niigata, Japan.

Hironobu Naiki (H)

Department of Molecular Pathology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Masanori Hara (M)

Iwamuro Health Promotion Center, Niigata, Japan.

Masayuki Iwano (M)

Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH